IntelligenceOverview
NewsBriefingJournalismTesseract
ExposureReportsNeural WebPlayersGeopoliticsSignal Map
MarketsMarket SignalsPulse
Entity

Wainua

Wainua is an experimental RNA interference (RNAi) drug developed by AstraZeneca for treating transthyretin amyloidosis (ATTR), a rare and fatal heart disease.

Why it’s in the news: It is in the news following the discontinuation of its late-stage clinical trial due to a failure to meet its primary endpoint.

Explore Wainua in the interactive graph

Latest on Wainua

  • STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua

Connections

3 entities linked to Wainua across the news graph.

Also connected to (3)
AstraZenecaAlnylamSTAT
Open the interactive Neural Web →Intelligence Briefs